Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -1867.60% is in line with its 5-year average of -1915.22%, near the high end of its 5-year range (-162626.00%–78.68%).
92.85% above its 12-month average of -26131.15%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): -2051.49%.
EBITDA MARGIN
-1867.60%
EBITDA MARGIN AVG TTM
-26131.15%
EBITDA MARGIN AVG 3Y
-1934.89%
EBITDA MARGIN AVG 5Y
-1915.22%
EBITDA MARGIN AVG 10Y
-9090.19%
EBITDA MARGIN AVG 15Y
-7098.51%
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+92.85%
CURRENT VS 3Y AVG
+3.48%
CURRENT VS 5Y AVG
+2.49%
CURRENT VS 10Y AVG
+79.45%
CURRENT VS 15Y AVG
+73.69%
CURRENT VS 20Y AVG
N/A
Prothena Corporation plc
Market Cap
$411.62M
EBITDA Margin
-1867.60%
TTM Avg
-26131.15%
3Y Avg
-1934.89%
5Y Avg
-1915.22%
Market Cap
$411.79M
EBITDA Margin
-1.71%
TTM Avg
-2.46%
3Y Avg
-6.59%
5Y Avg
-11.17%
Market Cap
$412.30M
EBITDA Margin
-7.84%
TTM Avg
-9.54%
3Y Avg
-19.72%
5Y Avg
-25.08%
Market Cap
$407.12M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$407.71M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
Market Cap
$407.02M
EBITDA Margin
-8579.24%
TTM Avg
-8579.24%
3Y Avg
-8579.24%
5Y Avg
-8579.24%
Market Cap
$402.33M
EBITDA Margin
39.39%
TTM Avg
8.38%
3Y Avg
8.38%
5Y Avg
8.38%
Market Cap
$403.70M
EBITDA Margin
-59.97%
TTM Avg
-74.12%
3Y Avg
-94.06%
5Y Avg
-94.06%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prothena Corporation plc (PRTA) | $411.62M | -1867.60% | -26131.15% | -1934.89% | -1915.22% |
| Myriad Genetics, Inc. (MYGN)vs › | $411.79M | -1.71% | -2.46% | -6.59% | -11.17% |
| Strata Critical Medical, Inc. (SRTA)vs › | $412.30M | -7.84% | -9.54% | -19.72% | -25.08% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $407.12M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $409.24M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $407.71M | -48.80% | -44.09% | -45.35% | -45.35% |
| Neurogene Inc. (NGNE)vs › | $407.02M | -8579.24% | -8579.24% | -8579.24% | -8579.24% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $402.33M | 39.39% | 8.38% | 8.38% | 8.38% |
| Carlsmed, Inc. (CARL)vs › | $403.70M | -59.97% | -74.12% | -94.06% | -94.06% |
| Senseonics Holdings, Inc. (SENS)vs › | $415.43M | -189.54% | -258.01% | -315.18% | -540.94% |
Gross Margin
61.8%
EBITDA Margin
-1867.6%
Operating Margin
-1905.8%
Net Margin
-80.7%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | -2051.49% |
| 2026-03-31 | 52.28% |
| 2025-12-31 | -125090.48% |
| 2025-09-30 | -1656.77% |
| 2025-06-30 | -1909.30% |
| 2025-03-31 | -2311.10% |
| 2024-12-31 | -3046.44% |
| 2024-09-30 | -6833.71% |
| 2024-06-30 | 44.40% |
| 2024-03-31 | -162626.00% |
| 2023-12-31 | -24759.18% |
| 2023-09-30 | 12.42% |
| 2023-06-30 | -1649.22% |
| 2023-03-31 | -2587.55% |
| 2022-12-31 | 0.25% |
| 2022-09-30 | -3305.87% |
| 2022-06-30 | -3279.34% |
| 2022-03-31 | -3275.11% |
| 2021-12-31 | -2803.07% |
| 2021-09-30 | 78.68% |
| 2021-06-30 | 47.01% |
| 2021-03-31 | -19878.13% |
| 2020-12-31 | -8318.33% |
| 2020-09-30 | -19400.64% |
| 2020-06-30 | -13513.33% |
| 2020-03-31 | -17350.35% |
| 2019-12-31 | -8935.16% |
| 2019-09-30 | -9395.12% |
| 2019-06-30 | -10061.68% |
| 2019-03-31 | -11437.10% |
| 2018-12-31 | -11303.61% |
| 2018-09-30 | -9227.06% |
| 2018-06-30 | -22319.00% |
| 2018-03-31 | -21106.17% |
| 2017-12-31 | -20320.96% |
| 2017-09-30 | -24094.52% |
| 2017-06-30 | -64.80% |
| 2017-03-31 | -13711.20% |
| 2016-12-31 | -28280.12% |
| 2016-09-30 | -14635.66% |
| 2016-06-30 | -11931.53% |
| 2016-03-31 | -10248.68% |
| 2015-12-31 | -7815.64% |
| 2015-09-30 | -5235.66% |
| 2015-06-30 | -6417.27% |
| 2015-03-31 | -2501.85% |
| 2014-12-31 | -641.38% |
| 2014-09-30 | -870.79% |
| 2014-06-30 | 11.58% |
| 2014-03-31 | 56.44% |
| 2013-12-31 | -6269.46% |
| 2013-09-30 | -5509.94% |
| 2013-06-30 | -6613.77% |
| 2013-03-31 | -5163.74% |
| 2012-12-31 | -2097.04% |
| 2012-09-30 | -909.96% |
| 2012-06-30 | -1305.58% |
| 2012-03-31 | -2648.02% |
